Physician profile
Eric Chung
NPI 1215303490
$4,770.17
in general payments reported to CMS, 2019-2025
15 companies · $1,127 in 2025
The $1,127 reported for 2025 was more than what 82% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $368 · 2022: $178 · 2023: $2,609 · 2024: $488 · 2025: $1,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,165 · Travel and Lodging: $2,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,165.04 |
| Travel and Lodging | $2,058.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,406.55 | 2021-2024 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Curonix LLC | $615.02 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Forte Bio-Pharma LLC | $424.46 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $338.68 | 2023-2025 | Belbuca |
| Spinal Simplicity, LLC | $236.34 | 2022-2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $194.17 | 2023-2024 | Portico, Proclaim |
| Virtus Pharmaceuticals LLC | $161.27 | 2023-2025 | Levorphanol Tartrate |
| Almatica Pharma LLC | $123.53 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $72.64 | 2025 | |
| Horizon Therapeutics Plc | $51.25 | 2021-2022 | |
| Saluda Medical Americas, INC. | $47.96 | 2025 | Evoke |
| Redhill Biopharma INC. | $34.52 | 2021 | |
| Zimmer Biomet Holdings, INC. | $22.24 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Painteq LLC | $21.70 | 2022 | |
| Si-Bone, INC. | $19.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.